OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction
Jérôme Lugrin, Roumen Parapanov, Giuseppina Milano, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 59

Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities
Ingo Hilgendorf, Stefan Frantz, Nikolaos G. Frangogiannis
Circulation Research (2024) Vol. 134, Iss. 12, pp. 1718-1751
Closed Access | Times Cited: 26

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4

IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction
Jianwu Huang, Wenlong Kuang, Zihua Zhou
Inflammopharmacology (2024)
Closed Access | Times Cited: 8

Metabolic signatures in post-myocardial infarction heart failure, including insights into prediction, intervention, and prognosis
Xueyan Peng, Jie Du, Yuan Wang
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116079-116079
Open Access | Times Cited: 11

Deciphering the mitochondria-inflammation axis: Insights and therapeutic strategies for heart failure
Baile Zuo, Fan Xiu, Dawei Xu, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112697-112697
Closed Access | Times Cited: 3

Causal effects of Inflammatory cytokines on Cardiovascular diseases: Insights from genetic evidence
Yuxiu Chen, Aifang Zhong
Heliyon (2024) Vol. 10, Iss. 15, pp. e35447-e35447
Open Access | Times Cited: 3

Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, double blind, randomized, placebo-controlled, phase IIa study.
Antonio Abbate, Benjamín Van Tassell, Vladimir Bogin, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 6, pp. 565-577
Closed Access | Times Cited: 3

Mortality, cardiac and cerebral damages reduction by IL-1 inhibition in a murine model of TTP
R. Müller, R. Cauchois, Marie Lagarde, et al.
Blood (2024) Vol. 143, Iss. 26, pp. 2791-2803
Open Access | Times Cited: 1

Numerical Modeling of Myocardial Infarction in Multivessel Coronary Lesion. I. Analysis of Some Model Scenarios
O.F. Voropaeva, Ch.A. Tsgoev
Mathematical Biology and Bioinformatics (2024) Vol. 19, Iss. 1, pp. 183-211
Open Access | Times Cited: 1

Cardiovascular Risk and Systemic Inflammation in Rheumatoid Arthritis: Comparative Insights with Psoriatic Arthritis
Mateusz Kęska, Wiktoria Suchy
Archives of Pharmacy Practice (2024) Vol. 15, Iss. 3, pp. 58-65
Open Access | Times Cited: 1

Gene expression analysis identifies hub genes and pathways distinguishing fatal from survivor outcomes of Ebola virus disease
Melvin Mensah‐Bonsu, Christopher Doss, Clay Gloster, et al.
FASEB BioAdvances (2024) Vol. 6, Iss. 9, pp. 298-310
Open Access

Page 1

Scroll to top